Skip to main content
. 2020 Jan 8;11(9):2531–2557. doi: 10.1039/c9sc03414e

Table 2. Target protein family based drug/compound enrichment analysis results of the large-scale DTI predictions.

Drug sets predicted to Enriched terms of the predicted drug sets
ChEBI structure classification (tool: BiNChE) Chemical structure classification (tool: DrugPattern) ATC codes (tool: DrugPattern) Experimentally identified known targets and families (tool: CSgator) Functions of the experimentally identified known targets (GO) (tool: CSgator) Disease indications (MeSH) (tool: CSgator) Disease indications (disease ontology) (tool: CSgator)
Enzymes CHEBI:133004 – bisbenzylisoquinoline alkaloid Indoles and derivatives Antineoplastic agents Kinase Phosphorylation (GO:0016310) Neoplasms (C04 (D009369)) Disease of cellular proliferation (DOID:14566)
CHEBI:50047 – organic amino compound Macrolides and Analogues Antivirals for systemic use Enzyme Cellular protein modification process (GO:0006464) Cardiovascular diseases (C14 (D002318)) Organ system cancer (DOID:0050686)
CHEBI:24698 – hydroxyflavone Drugs for obstructive airway diseases Camk (CAMK protein kinase group) Receptor signaling protein activity (GO:0005057) Urologic diseases (C12.777 (D014570)) Kidney disease (DOID:557)
CHEBI:24921 – isoquinoline alkaloid Ste (STE protein kinase group) Transferase activity (GO:0016740) Kidney diseases (C12.777.419 (D007674)) Urinary system disease (DOID:18)
Adenyl nucleotide binding (GO:0030554)
GPCRs CHEBI:33853 – phenols Morphinans Psycholeptics Small molecule receptor (family A GPCR) Cell–cell signaling (GO:0007267) Nervous system diseases (C10 (D009422)) Disease of mental health (DOID:150)
CHEBI:72720 – flavonoid oligomer Benzofurans Drugs for obstructive airway diseases Transporter Circulatory system process (GO:0003013) Cardiovascular diseases (C14 (D002318)) Central nervous system disease (DOID:331)
CHEBI:33822 – organic hydroxy compound Stilbenes Bile and liver therapy 7TM1 (family A G protein-coupled receptor) Plasma membrane region (GO:0098590) Neurologic manifestations (C23.888.592 (D009461)) Genetic disease (DOID:630)
CHEBI:33635 – polycyclic compound Antihistamines for systemic use Electrochemical transporter Transmembrane transporter activity (GO:0022857) Pituitary diseases (C19.700 (D010900)) Disease of metabolism (DOID:0014667)
Nuclear receptors CHEBI:51958 – organic polycyclic compound Steroids and steroid derivatives Antineoplastic agents Transcription factor Intracellular receptor signaling pathway (GO:0030522) Neoplasms (C04 (D009369)) Disease of cellular proliferation (DOID:14566)
CHEBI:33635 – polycyclic compound Morphinans Corticosteroids for systemic use Nuclear receptor Nucleic acid binding transcription factor activity (GO:0001071) Immune system diseases (C20 (D007154)) Cancer (DOID:162)
CHEBI:36615 – triterpenoid Prenol lipids Anti-acne preparations Cytochrome P450 Programmed cell death (GO:0012501) Hemic and lymphatic diseases (C15 (D006425)) Immune system disease (DOID:2914)
CHEBI:25872 – pentacyclic triterpenoid Stilbenes Analgesics AUXTRANS (Auxiliary transport protein) Positive regulation of apoptotic process (GO:0043065) Skin and connective tissue diseases (C17 (D017437)) Hypersensitivity reaction disease (DOID:0060056)
Sex hormones and modulators of the genital system
Ion channels CHEBI:47916 – flavonoid Morphinans Antihistamines for systemic use Ste (STE protein kinase group) Phosphorylation (GO:0016310) Neoplasms (C04 (D009369)) Disease of cellular proliferation (DOID:14566)
CHEBI:26004 – phenylpropanoid Benzopyrans Beta blocking agents Camk (CAMK protein kinase group) Receptor signaling protein activity (GO:0005057) Skin and connective tissue diseases (C17 (D017437)) Organ system cancer (DOID:0050686)
CHEBI:26195 – polyphenol Benzene and substituted derivatives Drugs for obstructive airway diseases Ion channel Transmembrane transport (GO:0055085) Neurologic manifestations (C10.597 (D009461)) Gastrointestinal system disease (DOID:77)
CHEBI:38443 – 1-benzopyran Analgesics Transporter Cell death (GO:0008219) Respiratory tract diseases (C08 (D012140)) Cardiovascular system disease (DOID:1287)
Others CHEBI:33822 – organic hydroxy compound Macrolactams Antimycobacterials Cytosolic other Proteasome complex (GO:0000502) Cardiovascular diseases (C14 (D002318)) Disease of anatomical entity (DOID:7)
CHEBI:26004 – phenylpropanoid Diazines Agents acting on the renin–angiotensin system ATP binding cassette Ribosome (GO:0005840) Nervous system diseases (C10 (D009422)) Cardiovascular system disease (DOID:1287)
CHEBI:47916 – flavonoid Carboxylic acids and derivatives Lipid modifying agents Cytochrome P450 Antigen processing and presentation (GO:0019882) Vascular diseases (C14.907 (D014652)) Disease of cellular proliferation (DOID:14566)
CHEBI:25036 – lignan Antivirals for systemic use Transporter Enzyme inhibitor activity (GO:0004857) Pathological conditions, signs and symptoms (C23 (D013568)) Primary bacterial infectious disease (DOID:0050338)
Phosphodiesterase
Renin (case study) CHEBI:35352 – organonitrogen compound Morphinans Antineoplastic agents Kinase Phosphorylation (GO:0016310) Neoplasms (C04 (D009369)) Disease of cellular proliferation (DOID:14566)
CHEBI:26188 – polyketide Macrolides and analogues Pituitary and hypothalamic hormones and analogues Tk (TK protein kinase group) Receptor signaling protein activity (GO:0005057) Cardiovascular diseases (C14 (D002318)) Organ system cancer (DOID:0050686)
CHEBI:46845 – N-alkylpiperazine Lactams Endocrine therapy Cmgc (CMGC protein kinase group) Adenyl nucleotide binding (GO:0030554) Vascular diseases (C14.907 (D014652)) Vascular disease (DOID:178)
CHEBI:37578 – halide Benzodiazepines Agc (AGC protein kinase group) Guanyl-nucleotide exchange factor activity (GO:0005085) Digestive system diseases (C06 (D004066)) Urinary system disease (DOID:18)